NDANASALSPRAY, METEREDPriority Review
Approved
Nov 2015
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NARCAN (naloxone hydrochloride) is a metered-dose nasal spray that rapidly reverses opioid overdose by competitively blocking opioid receptors in the central nervous system. It is indicated for emergency treatment of known or suspected opioid overdose, including respiratory depression caused by natural and synthetic opioids. The nasal formulation enables rapid, non-invasive administration by lay responders and healthcare providers.
Peak
Peak lifecycle status indicates stable market demand with established infrastructure; commercial teams are focused on market penetration and maintaining competitive positioning rather than launch-phase rapid scaling.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg
Started Oct 2022
24 enrolled
Opioid Overdose
Career Relevance
Working on NARCAN positions you in a mission-critical public health franchise with significant social impact and regulatory visibility. The product's peak lifecycle stage favors commercial strategy, market access negotiations, and public health partnerships over drug development roles.
Brand Manager
Worked on NARCAN at Emergent BioSolutions? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.